Agilent Technologies, Inc. - Diagnostics and Genomics SSXT CD GlasgowCancerCore, 96 A
The Agilent SureSelectXT Custom DNA Panel, CD GlasgowCancerCore (part number 5191-6731), is designed for targeted next-generation sequencing (NGS) applications. This panel enables researchers to enrich and sequence specific genomic regions associated with cancer, providing high sensitivity and specificity for variant detection. The kit supports up to 96 reactions and is optimized for use with the SureSelectXT workflow, ensuring efficient target enrichment and streamlined library preparation. It is suitable for use in cancer research and genomic profiling studies, offering reliable performance and reproducible results.